November 23, 2024 07:15 (IST)
Drug firm Moderna's COVID-19 vaccine shows positive result, share prices rise
New York/IBNS: American biotech company Moderna Inc said its COVID-19 vaccine, which is still in the test phase, has shown success in a small initial trial with the vaccine producing virus-neutralising antibodies similar to that found in patients recovered from the infection, triggering a rise in its share prices by 25 per cent.
Latest Headlines